UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 8)*
Sierra Health Services, Inc.
--------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------
(Title of Class of Securities)
826322-10-9
--------------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with the statement |_|. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13G
CUSIP No. 826322-10-9
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Anthony M. Marlon, M.D.
- --------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
- --------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
5 SOLE VOTING POWER
NUMBER OF 2,484,490 shares of Common Stock
SHARES
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY -0-
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 2,484,490 shares of Common Stock
WITH
8 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,484,490 shares of Common Stock
- --------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* |_|
- --------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
14.1%
- --------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13G
CUSIP No. 826322-10-9
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Marlon Family Trust
- --------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
- --------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
The assets of the trust have a situs in, and the trust is construed, enforced
and administered according to the laws of the State of Nevada.
5 SOLE VOTING POWER
NUMBER OF 644,638 shares of Common Stock
SHARES
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY -0-
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 644,638 shares of Common Stock
WITH
8 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
644,638 shares of Common Stock
- --------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* |_|
- --------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.6%
- --------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Item 1. (a) Name of Issuer:
Sierra Health Services, Inc.
(b) Address of Issuer's Principal Executive
Offices:
2724 North Tenaya Way
Las Vegas, Nevada 89128
Item 2. (a) Name of Persons Filing:
(i) Anthony M. Marlon, M.D.
("Dr. Marlon")
(ii) The Marlon Family Trust
(b) Address of Principal Business Office or,
if none, Residence:
(i), (ii) 2724 North Tenaya Way
Las Vegas, Nevada 89128
(c) Citizenship:
(i) United States of America (ii) The
assets of the trust have a situs in,
and the trust is construed,
enforced, and administered
according to the laws
of, the State of Nevada
(d) Title of Class of Securities:
Common Stock, $.005 par value
(e) CUSIP Number:
826322-10-9
Item 3. This statement is filed pursuant to Rule 13d-1(c).
Items 3(a) through 3(h) are, therefore,
inapplicable.
Item 4. Ownership
(a) Amount Beneficially Owned at December
31, 1995:
Amount beneficially owned by Dr. Marlon
at December 31, 1995: 2,484,490 shares,
including the shares described in the
following two paragraphs.
A total of 644,638 shares are held by
The Marlon Family Trust and beneficially
owned indirectly by Dr. Marlon in his
capacity as co-trustee of such trust.
A total of 1,833,852 shares are held
indirectly through a total of twelve
other trusts (the "Twelve Trusts"),
and 1,000 shares are held indirectly
through a limited partnership (the
"Partnership") in which Dr. Marlon
and his wife are the only
limited partners and general partners.
In addition, Dr. Marlon has a right to
acquire 5,000 shares within sixty days
of December 31, 1995 pursuant to options
exercisable within such period.
(b) Percent of Class:
(i) 14.1%
(ii) 3.6%
(c) Number of shares as to which Dr. Marlon
has:
(i) sole power to vote or to
direct the vote:
2,484,490 shares.
(ii) shared power to vote or to
direct the vote: 0 shares.
(iii) sole power to dispose or to
direct the disposition of:
2,484,490 shares.
(iv) shared power to dispose or
to direct the disposition of:
0 shares.
Either of Dr. Marlon or The Marlon
Family Trust may be deemed to have
voting and dispositive power over the
shares held by The Marlon Family Trust,
and, therefore, to have beneficial
ownership with respect to such shares.
Dr. Marlon, as managing general partner
of the Partnership, has sole voting and
dispositive power over the shares held
by the Partnership. Dr. Marlon may be
deemed to have or share voting power
and/or dispositive power over the shares
held by the other trusts described in
Item 4(a) and, therefore, to have
beneficial ownership with respect to
such shares.
Item 5. Ownership of Five Percent or Less of a Class
On December 31, 1995, The Marlon Family Trust owned less
than five percent of the outstanding class of securities.
Item 6. Ownership of More than Five Percent on Behalf of
Another Person
Not applicable.
<PAGE>
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the
Parent Holding Company
Not applicable.
Item 8. Identification and Classification of Members of the
Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification.
Not applicable. This statement is filed pursuant to Rule
13d-1(c).
<PAGE>
AGREEMENT PURSUANT TO RULE 13d-1(f)
Pursuant to Rule 13d-1(f)(1)(iii) under the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), each of the undersigned
agrees that this Amendment No. 8 to Schedule 13G is filed on behalf of each of
them, and that subsequent amendments hereto shall be filed on behalf of each of
them.
The filing of this Amendment to Schedule 13G and amendments
hereto, and the statements herein and therein, shall not be construed as an
admission that any filing person or any other person named herein is, for
purposes of Section 13(d), 13(g), 16(a), or 16(b) under the Exchange Act, or for
any other purpose, the beneficial owner of any of the securities described
herein or therein, except to the extent that a natural person is reported as
having voting and dispositive power, and thus beneficial ownership for purposes
of Sections 13(d) and 13(g), over securities owned directly by such person.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
February 9, 1996
----------------------------
Date
Anthony M. Marlon, M.D.
----------------------------
Anthony M. Marlon, M.D.
----------------------------
Name / Title
February 9, 1996
----------------------------
Date
THE MARLON FAMILY TRUST
By: Anthony M. Marlon, M.D.
-----------------------------
Signature
Anthony M. Marlon, Co-Trustee
-----------------------------
